These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Safety and efficacy of an intravenous loading dose of azathioprine for treatment of non-TPMT-deficient patients with rheumatic diseases. Pickenpack A; Straub RH; Distler O; Hammond A; Oellerich M; Schölmerich J; Lang B; Schütz E Rheumatology (Oxford); 2000 Dec; 39(12):1435-6. PubMed ID: 11136898 [No Abstract] [Full Text] [Related]
7. [Conservative local therapy of rheumatological diseases]. Rüther W; Casser HR; Hammer M Z Rheumatol; 2015 Nov; 74(9):763. PubMed ID: 26555658 [No Abstract] [Full Text] [Related]
8. Autoimmune rheumatic diseases: recent advances and current challenges. Cicuttini FM Med J Aust; 2017 Mar; 206(5):201-202. PubMed ID: 28301788 [No Abstract] [Full Text] [Related]
9. [Individualized therapy in treatment of rheumatic diseases]. Li ZG Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2449-50. PubMed ID: 17156668 [No Abstract] [Full Text] [Related]
11. Pediatric rheumatology for the adult rheumatologist I: therapy and dosing for pediatric rheumatic disorders. DeWitt EM; Sherry DD; Cron RQ J Clin Rheumatol; 2005 Feb; 11(1):21-33. PubMed ID: 16357693 [TBL] [Abstract][Full Text] [Related]
12. Special issue on glucocorticoid therapy in rheumatic diseases: introduction. Cutolo M; Chrousos GP; Pincus T Neuroimmunomodulation; 2015; 22(1-2):3-5. PubMed ID: 25227248 [No Abstract] [Full Text] [Related]
13. Drug therapy in adolescents with rheumatic diseases. Schaller JG Rev Rhum Engl Ed; 1997 Oct; 64(10 Suppl):194S-195S. PubMed ID: 9385680 [No Abstract] [Full Text] [Related]
14. The use of methotrexate in childhood rheumatic diseases. Wallace CA Arthritis Rheum; 1998 Mar; 41(3):381-91. PubMed ID: 9506564 [No Abstract] [Full Text] [Related]
15. [Individual and interdisciplinary treatment of rheumatic diseases in pregnancy]. Bolz M Dtsch Med Wochenschr; 2008 Nov; 133(46):2415. PubMed ID: 18988135 [No Abstract] [Full Text] [Related]
16. Addressing unmet clinical needs: the potential of biosimilars in the treatment of rheumatic diseases. Schulze-Koops H Rheumatology (Oxford); 2017 Aug; 56(suppl_4):iv1-iv3. PubMed ID: 28903541 [No Abstract] [Full Text] [Related]
17. Introduction to special section: biologic agents in the treatment of rheumatic diseases-the first decade. Yelin E; Katz P Arthritis Rheum; 2009 May; 61(5):559. PubMed ID: 19405010 [No Abstract] [Full Text] [Related]
18. Pharmacogenetics in the rheumatic diseases. Cronstein BN Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii25-ii27. PubMed ID: 15479867 [No Abstract] [Full Text] [Related]
19. Caveats to the use of parenteral methotrexate in the treatment of rheumatic disease. Moitra RK; Ledingham JM; Hull RG; McCrae FC; Thomas AL; Shaban R; Mackay KR Rheumatology (Oxford); 2005 Feb; 44(2):256-7. PubMed ID: 15637036 [No Abstract] [Full Text] [Related]